@article{b90cc279a3944539a67bc24f6ace214e,
title = "Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation",
keywords = "BRCA1, BRCA2, Breast cancer, Chemoprevention, Raloxifene, Tamoxifen",
author = "{and the Hereditary Breast Cancer Clinical Study Group} and Joanne Kotsopoulos and Jacek Gronwald and Tomasz Huzarski and Amber Aeilts and {Randall Armel}, Susan and Beth Karlan and Singer, {Christian F.} and Andrea Eisen and Nadine Tung and Olufunmilayo Olopade and Louise Bordeleau and Charis Eng and Foulkes, {William D.} and Neuhausen, {Susan L.} and Cullinane, {Carey A.} and Tuya Pal and Robert Fruscio and Jan Lubinski and Kelly Metcalfe and Ping Sun and Narod, {Steven A.} and Georgia Wiesner and Aletta Poll and Raymond Kim and Jeanna McCuaig and Dana Zakalik and Fergus Couch and Linda Steele and Howard Saal and Edmond Lemire and Kim Serfas and Kevin Sweet and Seema Panchal and Christine Elser and Reilly, {Robert E.} and Blum, {Joanne L.} and Cezary Cybulski and Daniel Rayson and Ram{\'o}n, {Teresa y.Cajal} and Jeffrey Dungan and Stefania Zovato and Antonella Rastelli and Pal Moller and Stephanie Cohen",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",
year = "2023",
month = sep,
doi = "10.1007/s10549-023-06991-3",
language = "English",
volume = "201",
pages = "257--264",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",
}
